Global and China Inflammatory Bowel Disease Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.2.4 Corticosteroids
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Hospital Use
1.3.3 Home Use
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Inflammatory Bowel Disease Therapeutics Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Inflammatory Bowel Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Market Size
3.1.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Inflammatory Bowel Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapeutics Revenue
3.4 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapeutics Revenue in 2019
3.5 Key Players Inflammatory Bowel Disease Therapeutics Area Served
3.6 Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Type (2021-2026)
5 Inflammatory Bowel Disease Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Inflammatory Bowel Disease Therapeutics Market Size (2015-2026)
6.2 North America Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020)
6.3 North America Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020)
6.4 North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease Therapeutics Market Size (2015-2026)
7.2 Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020)
7.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020)
7.4 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Inflammatory Bowel Disease Therapeutics Market Size (2015-2026)
8.2 China Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020)
8.3 China Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020)
8.4 China Inflammatory Bowel Disease Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Inflammatory Bowel Disease Therapeutics Market Size (2015-2026)
9.2 Japan Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020)
9.3 Japan Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020)
9.4 Japan Inflammatory Bowel Disease Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Introduction
11.1.4 Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020))
11.1.5 Abbvie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Inflammatory Bowel Disease Therapeutics Introduction
11.4.4 Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Inflammatory Bowel Disease Therapeutics Introduction
11.5.4 Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
11.5.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Anti-inflammatory Biologics
Table 4. Key Players of Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Table 5. Key Players of Corticosteroids
Table 6. Global Inflammatory Bowel Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Inflammatory Bowel Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Inflammatory Bowel Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions (2015-2020)
Table 10. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions (2021-2026)
Table 12. Inflammatory Bowel Disease Therapeutics Market Market Trends
Table 13. Inflammatory Bowel Disease Therapeutics Market Drivers
Table 14. Inflammatory Bowel Disease Therapeutics Market Challenges
Table 15. Inflammatory Bowel Disease Therapeutics Market Restraints
Table 16. Global Inflammatory Bowel Disease Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Inflammatory Bowel Disease Therapeutics Market Share by Players (2015-2020)
Table 18. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2019)
Table 19. Global Inflammatory Bowel Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Inflammatory Bowel Disease Therapeutics Market Size Share by Type (2015-2020)
Table 25. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 26. Global Inflammatory Bowel Disease Therapeutics Market Size Share by Application (2015-2020)
Table 27. Global Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Inflammatory Bowel Disease Therapeutics Market Size Share by Application (2021-2026)
Table 29. North America Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Inflammatory Bowel Disease Therapeutics Market Share by Type (2015-2020)
Table 31. North America Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Inflammatory Bowel Disease Therapeutics Market Share by Application (2015-2020)
Table 33. North America Inflammatory Bowel Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Inflammatory Bowel Disease Therapeutics Market Share by Country (2015-2020)
Table 35. Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Inflammatory Bowel Disease Therapeutics Market Share by Type (2015-2020)
Table 37. Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Inflammatory Bowel Disease Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Inflammatory Bowel Disease Therapeutics Market Share by Country (2015-2020)
Table 41. China Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 42. China Inflammatory Bowel Disease Therapeutics Market Share by Type (2015-2020)
Table 43. China Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 44. China Inflammatory Bowel Disease Therapeutics Market Share by Application (2015-2020)
Table 45. China Inflammatory Bowel Disease Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 46. China Inflammatory Bowel Disease Therapeutics Market Share by Region (2015-2020)
Table 47. Japan Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Inflammatory Bowel Disease Therapeutics Market Share by Type (2015-2020)
Table 49. Japan Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Inflammatory Bowel Disease Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Inflammatory Bowel Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Inflammatory Bowel Disease Therapeutics Market Share by Country (2015-2020)
Table 53. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Share by Type (2015-2020)
Table 55. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Share by Country (2015-2020)
Table 59. Abbvie Company Details
Table 60. Abbvie Business Overview
Table 61. Abbvie Product
Table 62. Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020) (US$ Million)
Table 63. Abbvie Recent Development
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Product
Table 67. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020) (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Product
Table 72. GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020) (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020) (US$ Million)
Table 78. Merck Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2015-2020) (US$ Million)
Table 83. Novartis Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Inflammatory Bowel Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Anti-inflammatory Biologics Features
Figure 3. Non-Steroidal Anti-inflammatory drugs (NSAIDs) Features
Figure 4. Corticosteroids Features
Figure 5. Global Inflammatory Bowel Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Use Case Studies
Figure 7. Home Use Case Studies
Figure 8. Inflammatory Bowel Disease Therapeutics Report Years Considered
Figure 9. Global Inflammatory Bowel Disease Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions (2021-2026)
Figure 12. Global Inflammatory Bowel Disease Therapeutics Market Share by Players in 2019
Figure 13. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapeutics Revenue in 2019
Figure 15. North America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Abbvie Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
Figure 43. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
Figure 44. GlaxoSmithKline Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
Figure 45. Merck Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
Figure 46. Novartis Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed